能识别ALK和NPM1::ALK融合蛋白的内源性CD4+T细胞可以从人体外周血液中扩展
Serena Stadler1,2,3,4,5, Rafael B Blasco2, Vijay Kumar Singh1
1Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany.
Cancer immunology research
|January 8, 2025
概括
这项研究在ALK阳性淋巴瘤患者中鉴定了形淋巴瘤激酶 (ALK) 特定的CD4+T细胞. 这些发现揭示了关键的标表位,并支持CD4+ T细胞用于未来的癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 无细胞淋巴瘤激酶 (ALK) 融合蛋白是癌症免疫疗法的关键标.
- 虽然已知ALK特异性CD8+ T细胞,但ALK特异性CD4+ T细胞在ALK阳性恶性瘤中仍未得到充分研究.
研究的目的:
- 调查ALK阳性形大细胞淋巴瘤患者中ALK特异性CD4+T细胞的存在和特征.
- 为了识别这些CD4+T细胞识别的特定表位.
- 探索CD4+ T细胞在针对ALK的癌症免疫疗法的潜力.
主要方法:
- 从缓解期患者和健康捐赠者的外周血液查.
- 通过使用ALK池脉冲的自身树突细胞进行刺激.
- T细胞受体 (TCR) 测序以确定融合特异性TCR和功能验证.
主要成果:
- 在大多数被查的个体中检测到ALK特定的CD4+T细胞.
- 在ALK融合蛋白中确定了三个主要的表位区域.
- 一个特定的TCR的特征识别NPM1::ALK融合新表位,证明HLA-DR13的限制.
结论:
- 在人类外周血液中发现ALK特异性CD4+T细胞的证据.
- 定义的标表位可为免疫疗法开发提供见解.
- 支持将CD4+ T细胞纳入针对ALK向的癌症免疫治疗策略.
相关概念视频
T Cell Activation and Clonal Selection
651
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
651
Antigens Involved in Adaptive Immunity
450
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
450


